Logo image of CFX

COLFAX CORP (CFX) Stock Fundamental Analysis

USA - NYSE:CFX - Common Stock

39.06
-1.53 (-3.77%)
Last: 4/4/2022, 8:16:47 PM
39.06
0 (0%)
After Hours: 4/4/2022, 8:16:47 PM
Fundamental Rating

2

Taking everything into account, CFX scores 2 out of 10 in our fundamental rating. CFX was compared to 130 industry peers in the Machinery industry. CFX has a bad profitability rating. Also its financial health evaluation is rather negative. CFX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CFX was profitable.
CFX Yearly Net Income VS EBIT VS OCF VS FCFCFX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 200M -200M -400M

1.2 Ratios

Industry RankSector Rank
ROA 0.84%
ROE 1.55%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CFX Yearly ROA, ROE, ROICCFX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 5 -5 -10 -15

1.3 Margins

Industry RankSector Rank
OM 8.76%
PM (TTM) 1.86%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CFX Yearly Profit, Operating, Gross MarginsCFX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 10 -10 20 30 40

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for CFX has been increased compared to 1 year ago.
CFX has a better debt/assets ratio than last year.
CFX Yearly Shares OutstandingCFX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M
CFX Yearly Total Debt VS Total AssetsCFX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of 1.76, we must say that CFX is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 0.45 indicates that CFX is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 1.76
ROIC/WACCN/A
WACCN/A
CFX Yearly LT Debt VS Equity VS FCFCFX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 1B 2B 3B 4B

2.3 Liquidity

CFX has a Current Ratio of 2.25. This indicates that CFX is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 1.49 indicates that CFX should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 1.49
CFX Yearly Current Assets VS Current LiabilitesCFX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B

More info and screens

5

3. Growth

3.1 Past

CFX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 53.24%, which is quite impressive.
The Earnings Per Share has been growing slightly by 6.43% on average over the past years.
The Revenue has grown by 25.51% in the past year. This is a very strong growth!
CFX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.88% yearly.
EPS 1Y (TTM)53.24%
EPS 3Y-2.81%
EPS 5Y6.43%
EPS Q2Q%15.69%
Revenue 1Y (TTM)25.51%
Revenue growth 3Y20.68%
Revenue growth 5Y3.88%
Sales Q2Q%23.57%

3.2 Future

CFX is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -6.00% yearly.
The Revenue is expected to grow by 4.73% on average over the next years.
EPS Next Y241.51%
EPS Next 2Y13.59%
EPS Next 3Y11.71%
EPS Next 5Y-6%
Revenue Next Year7.2%
Revenue Next 2Y6.23%
Revenue Next 3Y5.31%
Revenue Next 5Y4.73%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CFX Yearly Revenue VS EstimatesCFX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B
CFX Yearly EPS VS EstimatesCFX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

CFX is valuated rather expensively with a Price/Earnings ratio of 18.34.
When comparing the Price/Earnings ratio of CFX to the average of the S&P500 Index (27.42), we can say CFX is valued slightly cheaper.
CFX is valuated cheaply with a Price/Forward Earnings ratio of 5.37.
When comparing the Price/Forward Earnings ratio of CFX to the average of the S&P500 Index (22.94), we can say CFX is valued rather cheaply.
Industry RankSector Rank
PE 18.34
Fwd PE 5.37
CFX Price Earnings VS Forward Price EarningsCFX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.44
CFX Per share dataCFX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

CFX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.08
PEG (5Y)2.85
EPS Next 2Y13.59%
EPS Next 3Y11.71%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CFX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COLFAX CORP

NYSE:CFX (4/4/2022, 8:16:47 PM)

After market: 39.06 0 (0%)

39.06

-1.53 (-3.77%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-22 2022-02-22/bmo
Earnings (Next)04-28 2022-04-28/bmo
Inst Owners0%
Inst Owner Change0%
Ins Owners1.27%
Ins Owner Change0%
Market Cap6.10B
Analysts78.95
Price Target51.43 (31.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.34
Fwd PE 5.37
P/S 1.58
P/FCF N/A
P/OCF N/A
P/B 1.32
P/tB N/A
EV/EBITDA 12.44
EPS(TTM)2.13
EY5.45%
EPS(NY)7.27
Fwd EY18.62%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS24.67
BVpS29.55
TBVpSN/A
PEG (NY)0.08
PEG (5Y)2.85
Profitability
Industry RankSector Rank
ROA 0.84%
ROE 1.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 8.76%
PM (TTM) 1.86%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.25
Quick Ratio 1.49
Altman-Z 1.76
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)53.24%
EPS 3Y-2.81%
EPS 5Y6.43%
EPS Q2Q%15.69%
EPS Next Y241.51%
EPS Next 2Y13.59%
EPS Next 3Y11.71%
EPS Next 5Y-6%
Revenue 1Y (TTM)25.51%
Revenue growth 3Y20.68%
Revenue growth 5Y3.88%
Sales Q2Q%23.57%
Revenue Next Year7.2%
Revenue Next 2Y6.23%
Revenue Next 3Y5.31%
Revenue Next 5Y4.73%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A